AKAM vs REPL · P/E 27, $11.31B cap vs $825.7M cap
Akamai Technologies Inc (AKAM) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
AKAM does not have a complete income-statement cache yet.
REPL does not have a complete income-statement cache yet.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. REPL currently screens at market cap $825.7M.
Not investment advice. Open the AKAM and REPL stock pages for the full models.
Not investment advice.